Discovery Scientists, in vitro and in vivo Pharmacology, in Cardiovascular & Metabolic Disease

Bei Roche kannst du ganz du selbst sein und wirst für deine einzigartigen Qualitäten geschätzt. Unsere Kultur fördert persönlichen Ausdruck, offenen Dialog und echte Verbindungen. Hier wirst du für das, was du bist, wertgeschätzt, akzeptiert und respektiert. Dies schafft ein Umfeld, in dem du sowohl persönlich als auch beruflich wachsen kannst. Gemeinsam wollen wir Krankheiten vorbeugen, stoppen und heilen und sicherstellen, dass jeder Zugang zur Gesundheitsversorgung hat – heute und in Zukunft.

Werde Teil von Roche, wo jede Stimme zählt.

In Roche’s Pharmaceutical Research and Early Development organization (pRED), we make transformative medicines for patients in order to tackle some of the world’s toughest unmet healthcare needs. At pRED, we are united by our mission to transform science into medicines. Together, we create a culture defined by curiosity, responsibility and humility, where our talented people are empowered and inspired to bring forward extraordinary life-changing innovation at speed.

pRED Cardiovascular & Metabolism, Immunology (CMI), located in Basel, Switzerland, focuses on the discovery and early development of innovative treatments for specific diseases that affect the lives of millions. In the cardiovascular and metabolism area, we are developing cutting‑edge therapies to treat metabolic diseases.

We are currently hiring four experienced PhD-level Discovery Scientists to join our Cardiovascular & Metabolic Disease Research team:
These opportunities include two in vivo‑focused and two in vitro‑focused positions
, offering the chance to contribute to innovative preclinical research in metabolic diseases. We are looking for candidates with strong expertise in in vitro and/or in vivo pharmacology, a solid industry background, and a proven track record in executing preclinical projects in metabolic diseases and immunology.

In this role, you will design and execute experiments and lead projects to evaluate the efficacy and safety of novel therapeutic candidates.

• Lead research projects in the area of metabolic diseases (insulin resistance, obesity) from target ideation to entry into clinical development for both small‑ and large‑molecule modalities.

• Drive the positioning and prioritization of novel metabolic and immunological targets, integrating disease biology, translational biomarkers, and therapeutic modality selection to align with Roche’s CVM pipeline.

• Collaboratively design, execute, and interpret complex preclinical in vitro and in vivo experimental studies for the validation and characterization of targets or therapeutic agents.

• Direct, execute, and benchmark novel experiments, work together hand in hand with associates, and transfer standardized assays to associates.

• Act as a resource in project teams, and demonstrate clear and professional verbal and written communication.

You’re someone who wants to influence your own development. You are looking for a company where you receive the opportunity to pursue your interests across functions and geographies. Working in a multicultural environment motivates you. As a fast learner, you actively drive the quality of the requirements.

• You possess a PhD degree in Life Sciences
  ; are specialized in Metabolic diseases (insulin resistance, obesity, muscle-/adipose-physiology).

• You have 5 years of research and project leadership experience in the pharmaceutical industry
  .

• You have demonstrated ability to effectively present scientific data and concepts to colleagues, teams, and management.

• Skillfully able to interact effectively with people, both internally and externally.

• Vigorous “can do” mentality to succeed in a dynamic and highly collaborative research team.

• Depending on your background, this role is embedded in an in vivo‑focused or in vitro‑focused research team.

Roche ist ein Arbeitgeber, der die Chancengleichheit fördert.